You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR CLINDAMYCIN PHOSPHATE; TRETINOIN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for clindamycin phosphate; tretinoin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00823901 ↗ Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea Completed Medicis Pharmaceutical Corporation Phase 2/Phase 3 2009-02-01 The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel are effective and safe in the treatment of papulopustular rosacea.
NCT00823901 ↗ Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea Completed Massachusetts General Hospital Phase 2/Phase 3 2009-02-01 The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel are effective and safe in the treatment of papulopustular rosacea.
NCT00838812 ↗ Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate Completed Igefarma Laboratorios S.A. Phase 3 2009-03-01 The purpose of this study is to determine the safety and efficacy of association between tretinoin and clindamycin phosphate on the treatment of acne vulgaris mild and moderate.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for clindamycin phosphate; tretinoin

Condition Name

Condition Name for clindamycin phosphate; tretinoin
Intervention Trials
Acne Vulgaris 5
MILD TO SEVERE ACNE VULGARIS 1
Rosacea 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for clindamycin phosphate; tretinoin
Intervention Trials
Acne Vulgaris 6
Neoplasm Metastasis 1
Hyperpigmentation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for clindamycin phosphate; tretinoin

Trials by Country

Trials by Country for clindamycin phosphate; tretinoin
Location Trials
United States 7
India 1
Brazil 1
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for clindamycin phosphate; tretinoin
Location Trials
New York 2
Pennsylvania 1
Maryland 1
North Carolina 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for clindamycin phosphate; tretinoin

Clinical Trial Phase

Clinical Trial Phase for clindamycin phosphate; tretinoin
Clinical Trial Phase Trials
Phase 4 4
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for clindamycin phosphate; tretinoin
Clinical Trial Phase Trials
Completed 5
Unknown status 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for clindamycin phosphate; tretinoin

Sponsor Name

Sponsor Name for clindamycin phosphate; tretinoin
Sponsor Trials
Zeichner, Joshua, M.D. 2
Medicis Pharmaceutical Corporation 2
Wake Forest University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for clindamycin phosphate; tretinoin
Sponsor Trials
Other 9
Industry 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.